The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment DOI Creative Commons
Tianhang Zhang, Haitao Lv,

J. Li

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Дек. 24, 2024

Background The occurrence of immune-related adverse events (irAEs) seemed to be associated with better outcomes in advanced gastric cancer (AGC) patients. However, research focusing on the impact single-organ irAE (uni-irAE) or multi-organ irAEs (multi-irAEs) AGC outcome is relatively limited. In this study, we investigated individually different survival as well co-occurrence patterns multi-irAEs. Methods uni-irAE, multi-irAEs, and non-irAE were identified based National Comprehensive Cancer Network (NCCN) guidelines. ICI efficacy for disease control rate (DCR) objective response (ORR) was assessed Response Evaluation Criteria Solid Tumors (RECIST) Version 1.1. association progression-free (PFS) overall (OS) analyzed using Kaplan–Meier method Cox regression model. We also performed pairwise correlation analysis identify irAEs. Results A total 288 patients including 175 non-irAE, 73 40 multi-irAE evaluated their outcome. displayed higher DCR (78.8% vs. 67.4%, p =0.037) when compared those patients, both uni-irAE (82.2% =0.019) (72.5% =0.534) showed than that multivariate analyses revealed multi-irAEs an independent risk factor PFS (hazard ratio [HR] 0.63, 95% confidence interval [CI] 0.41~0.96, =0.031) OS (HR 0.47, CI 0.29~0.76, =0.002), whereas not obtained. thyroid, adrenal gland, heart, skin, lung exhibited a high organ-specific experiencing skin had favorable without these Conclusion Multi-irAEs some can used predictive indicators treatment are often accompanied by occurrence.

Язык: Английский

Immunotherapeutic effects of de novo benzimidazole derivative and prebiotic bacterial levan against triple-negative breast tumors by harnessing the immune landscape to intercept the oncogenic transcriptome DOI
Heba Shawky, Dalia B. Fayed, Somaia S. Abd El‐Karim

и другие.

International Journal of Biological Macromolecules, Год журнала: 2024, Номер 289, С. 138844 - 138844

Опубликована: Дек. 18, 2024

Язык: Английский

Процитировано

1

Alterations in Gut Archaea Composition and Their Bacterial Interactions Linked to Hypertension DOI
Wen Yuan,

Yihang Chen,

Lirong Liang

и другие.

medRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Апрель 27, 2024

Abstract Alterations in the gut microbiota have been linked to hypertension, with role of archaea, despite being stable constituents, remaining largely unexplored. Shotgun metagenomic analyses fecal samples were performed on 341 participants from 3 cohorts: discovery cohort (88 individuals), validation 1 (175 and 2 (78 individuals). Principal Coordinates Analysis (PCoA) based Bray-Curtis distances revealed significant alterations composition enteric archaea between control individuals hypertensive patients (P < 0.05). Hypertensive groups showed reduced abundances halophilic (Halorhabdus, Halovivax, Halorubrum_lipolyticum) methanogenic (Methanomassiliicoccus Candidatus_Methanomassiliicoccus_intestinalis). Eleven species, depleted patients, distinguished them individuals, areas under receiver operating characteristic curve 0.85, 0.79, 0.91 discovery, 1, 2, respectively. Significant correlations observed these clinical data across cohorts. Additionally, a positive correlation richness bacteria suggests close cross-kingdom synergy within microbiome. This study highlights shifts archaeal populations underscoring potential biomarkers hypertension diagnosis suggesting avenues for future therapeutic research.

Язык: Английский

Процитировано

0

Delineating the nexus between gut-intratumoral microbiome and osteo-immune system in bone metastases DOI Creative Commons

Shreya Kapoor,

Muskan Gupta,

Leena Sapra

и другие.

Bone Reports, Год журнала: 2024, Номер 23, С. 101809 - 101809

Опубликована: Окт. 11, 2024

Emerging insights in osteoimmunology have enabled researchers to explore depth the role of immune modulation regulating bone health. Bone is one common sites metastasis notably case breast cancer, prostate cancer and several other types. High calcium ion concentration presence factors within mineralized matrix including TGF-β, BMP etc., aid tumor growth proliferation. Accumulating evidence has substantiated gut-microbiota (GM) tumorigenesis, further providing a strong impetus for growing "immune-cancer-gut microbiota" relationship. Recent advancements research highlight importance intra-tumor microbiota conjunction with GM metastasis. Intratumoral owing their ability cause genetic instability, mutations, epigenetic modifications microenvironment, been recognized affect cell physiology. The host system crosstalk shapes innate adaptive arms system, which key player progression. In this review, we aim decipher microorganisms mediating by shedding light on immuno-onco-microbiome (IOM) axis. We discussed feasible therapeutic interventions based microbiome-immune axis includes prebiotics, probiotics, postbiotics. Here, leverage conceptual framework published articles microbiota-based therapies target metastases. Understanding complicated nexus will provide into fundamental governing metastases subsequently help managing malignancy better efficacy.

Язык: Английский

Процитировано

0

The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment DOI Creative Commons
Tianhang Zhang, Haitao Lv,

J. Li

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Дек. 24, 2024

Background The occurrence of immune-related adverse events (irAEs) seemed to be associated with better outcomes in advanced gastric cancer (AGC) patients. However, research focusing on the impact single-organ irAE (uni-irAE) or multi-organ irAEs (multi-irAEs) AGC outcome is relatively limited. In this study, we investigated individually different survival as well co-occurrence patterns multi-irAEs. Methods uni-irAE, multi-irAEs, and non-irAE were identified based National Comprehensive Cancer Network (NCCN) guidelines. ICI efficacy for disease control rate (DCR) objective response (ORR) was assessed Response Evaluation Criteria Solid Tumors (RECIST) Version 1.1. association progression-free (PFS) overall (OS) analyzed using Kaplan–Meier method Cox regression model. We also performed pairwise correlation analysis identify irAEs. Results A total 288 patients including 175 non-irAE, 73 40 multi-irAE evaluated their outcome. displayed higher DCR (78.8% vs. 67.4%, p =0.037) when compared those patients, both uni-irAE (82.2% =0.019) (72.5% =0.534) showed than that multivariate analyses revealed multi-irAEs an independent risk factor PFS (hazard ratio [HR] 0.63, 95% confidence interval [CI] 0.41~0.96, =0.031) OS (HR 0.47, CI 0.29~0.76, =0.002), whereas not obtained. thyroid, adrenal gland, heart, skin, lung exhibited a high organ-specific experiencing skin had favorable without these Conclusion Multi-irAEs some can used predictive indicators treatment are often accompanied by occurrence.

Язык: Английский

Процитировано

0